Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IMP9064 + Senaparib |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IMP9064 | IMP-9064|IMP 9064 | ATR Inhibitor 16 | IMP9064 binds to and inhibits ATR, resulting in inhibition of downstream signaling and impaired DNA damage repair, potentially leading to induction of apoptosis in tumor cells and antitumor activity (NCI Drug Dictionary, Ann Oncol 34 (2023): S476-S477). | |
Senaparib | IMP-4297|IMP4297|IMP 4297 | PARP Inhibitor (Pan) 31 | Senaparib (IMP-4297) inhibits PARP1 and PARP2, potentially leading to anti-tumor activity (PMID: 38920409). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|